Company Information

Founded in
5,001 - 10,000( View All )
Medication for cardiological and rheumatological conditionsas well as for diabetes and clinical depression
Servier is a global pharmaceutical group governed by a Foundation. Relying on a solid geographical presence and revenue of €4.7 billion in 2020 achieved in 150 countries, Servier employs 22,500 people worldwide. Servier is an independent group that invests over 20% of its brand-name revenue in Research and Development every year. To accelerate therapeutic innovation for the benefit of patients, the Group is committed to open and collaborative innovation with academic partners, pharmaceutical groups, and biotech companies. It also integrates the patient’s voice at the heart of its activities, from research to support beyond the pill. A leader in cardiology, the ambition of the Servier Group is to become a renowned and innovative player in oncology. Its growth is based on a sustained commitment to cardiovascular and metabolic diseases, oncology, neuroscience and immuno-inflammatory diseases. To promote access to healthcare for all, the Servier Group also offers a range of quality generic drugs covering most pathologies. -- To report a suspected adverse event with a Servier drug, please visit

Servier has 9,000+ contacts, the majority of which in AroundDeal database are in Healthcare Services.


Sign Up to View Servier’s Top Employees

5 free contacts every month.

Start with AroundDeal For Free!

Use AroundDeal to build prospect lists in 1 click.

5 free contacts every month.

Get Contact Info for All Employees


Claude Bertrand

Executive Vice President R&D, Chief Scientific Officer

Pei Zhang

Learning, Talent & Organizational Development Lead for China, HR CoE

Harold Dumont

Head of Oncology Business Unit GCC (ad interim)

Jing Meng

Procurement Associate Director

Sisir Bhattacharya

Senior Director, Global Head of MSAT (Manufacturing Science and Analytical Technology)